Status:
TERMINATED
Pulsed Electromagnetic Fields (PEMF) and Post-Axillary Surgery Morbidity
Lead Sponsor:
Columbia University
Conditions:
Shoulder Symptoms After Lymph Node Dissection
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The most important prognostic indicator for the breast cancer patient is the axillary lymph node status. With the introduction of the sentinel lymph node biopsy, many women were spared the morbidity o...
Detailed Description
In the treatment arm, the PEMF would be automatically delivered for 15 minutes every two hours for one month. The manufacturer (Ivivi Technologies, Inc., Northvale, NJ) has already designed a lightwei...
Eligibility Criteria
Inclusion
- Inclusion criteria include patients undergoing axillary lymph node dissection or sentinel lymph node dissection for breast cancer. Patients undergoing lumpectomy with the axillary surgery will be included.
Exclusion
- Patients undergoing mastectomy with the axillary surgery will be excluded.
- Patients with prior axillary radiation or prior arm impairment will be excluded.
- Patients with pacemakers will be excluded.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01255631
Start Date
October 1 2010
End Date
July 1 2012
Last Update
October 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032